LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-2.49 Cr | ₹-13 Cr | ₹39 Cr | ₹-12 Cr | ₹-61 Cr |
What is the latest Consolidated Net Profit of LYKA LABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹-2.49 Cr |
| Mar2024 | ₹-13 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹-12 Cr |
| Mar2021 | ₹-61 Cr |
How is Consolidated Net Profit of LYKA LABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.49 Cr | Negative | |
| Mar2024 | ₹-13 Cr | Negative | |
| Mar2023 | ₹39 Cr | Positive | |
| Mar2022 | ₹-12 Cr | Negative | |
| Mar2021 | ₹-61 Cr | - | |
Compare Consolidated Net Profit of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹270.9 Cr | 0.5% | -8.7% | -50.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,494.0 Cr | -1.5% | -4.8% | -4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,514.0 Cr | -0.9% | -1.4% | 11.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,044.0 Cr | 0.3% | 1.6% | 12.1% | Stock Analytics | |
| CIPLA | ₹121,574.0 Cr | -0.8% | -1.2% | 1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,919.0 Cr | -0.8% | 1.7% | -5.6% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 0.5% |
-8.7% |
-50.3% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses